WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2026)
Top health information service stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...
OverviewZen RatingPriceValueGrowthFinancialsMomentumSentimentForecastDividendsDue Diligence
B
Health Information Services is Zen Rated B and is the 42nd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
DD Score
Valuation Score
Financials Score
Forecast Score
Performance Score
Dividends Score
NUTX
NUTEX HEALTH INC
51
71
71
22
40
–
OPRX
OPTIMIZERX CORP
24
14
71
0
10
–
CCLD
CARECLOUD INC
39
29
71
44
10
–
TBRG
TRUBRIDGE INC
29
57
43
44
0
0
DH
DEFINITIVE HEALTHCARE CORP
14
14
43
0
0
–

Upgrade to Premium to View More

Use Due Diligence Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail.

Already have access to Premium? Sign In
12345...11

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Nutex Health (NASDAQ:NUTX)


Nutex Health (NASDAQ:NUTX) is the #1 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Nutex Health (NASDAQ:NUTX) is: Value: A, Growth: C, Momentum: C, Sentiment: C, Safety: F, Financials: B, and AI: C.

Nutex Health (NASDAQ:NUTX) has a Due Diligence Score of 51, which is 24 points higher than the health information service industry average of 27.

NUTX passed 16 out of 33 due diligence checks and has strong fundamentals. Nutex Health has seen its stock return 303.51% over the past year, overperforming other health information service stocks by 330 percentage points.

Nutex Health has an average 1 year price target of $205.00, an upside of 34.19% from Nutex Health's current stock price of $152.77.

Nutex Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nutex Health, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Optimizerx (NASDAQ:OPRX)


Optimizerx (NASDAQ:OPRX) is the #2 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Optimizerx (NASDAQ:OPRX) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Optimizerx (NASDAQ:OPRX) has a Due Diligence Score of 24, which is -3 points lower than the health information service industry average of 27. Although this number is below the industry average, our proven quant model rates OPRX as a "A".

OPRX passed 7 out of 33 due diligence checks and has weak fundamentals. Optimizerx has seen its stock return 150% over the past year, overperforming other health information service stocks by 177 percentage points.

Optimizerx has an average 1 year price target of $19.67, an upside of 61.87% from Optimizerx's current stock price of $12.15.

Optimizerx stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Optimizerx, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Carecloud (NASDAQ:CCLD)


Carecloud (NASDAQ:CCLD) is the #3 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Carecloud (NASDAQ:CCLD) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: A, Financials: B, and AI: C.

Carecloud (NASDAQ:CCLD) has a Due Diligence Score of 39, which is 12 points higher than the health information service industry average of 27.

CCLD passed 12 out of 33 due diligence checks and has average fundamentals. Carecloud has seen its stock return 9.43% over the past year, overperforming other health information service stocks by 36 percentage points.

What are the health information service stocks with highest dividends?

Out of 5 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.51%, which is 7 percentage points higher than the health information service industry average of 2.72%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. National Research (NASDAQ:NRC)


National Research (NASDAQ:NRC) has an annual dividend yield of 2.34%, which is the same as the health information service industry average of 2.72%. National Research's dividend payout is not stable, having dropped more than 10% four times in the last 10 years. National Research's dividend has not shown consistent growth over the last 10 years.

National Research's dividend payout ratio of 67.6% indicates that its dividend yield is sustainable for the long-term.

3. So Young International (NASDAQ:SY)


So Young International (NASDAQ:SY) has an annual dividend yield of 0.99%, which is -2 percentage points lower than the health information service industry average of 2.72%.

So Young International's dividend payout ratio of -2.6% indicates that its dividend yield might not be sustainable for the long-term.

Why are health information service stocks down?

Health information service stocks were down -1.01% in the last day, and down -7.28% over the last week.

We couldn't find a catalyst for why health information service stocks are down.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Nutex Health (NASDAQ:NUTX)


Nutex Health (NASDAQ:NUTX) is the most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 71, which is 51 points higher than the health information service industry average of 20. It passed 5 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 303.51% in the past year. It has overperformed other stocks in the health information service industry by 330 percentage points.

2. Goodrx Holdings (NASDAQ:GDRX)


Goodrx Holdings (NASDAQ:GDRX) is the second most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Goodrx Holdings has a valuation score of 86, which is 66 points higher than the health information service industry average of 20. It passed 6 out of 7 valuation due diligence checks.

Goodrx Holdings's stock has dropped -39.37% in the past year. It has underperformed other stocks in the health information service industry by -13 percentage points.

3. Solventum (NYSE:SOLV)


Solventum (NYSE:SOLV) is the third most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Solventum has a valuation score of 43, which is 23 points higher than the health information service industry average of 20. It passed 3 out of 7 valuation due diligence checks.

Solventum's stock has gained 9.34% in the past year. It has overperformed other stocks in the health information service industry by 36 percentage points.

Are health information service stocks a good buy now?

48.72% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 36.48% over the next year.

8.89% of health information service stocks have a Zen Rating of A (Strong Buy), 22.22% of health information service stocks are rated B (Buy), 53.33% are rated C (Hold), 13.33% are rated D (Sell), and 2.22% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 27.89x.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.